This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buseyne, F Articles by Rivière, Y Search for Related Content PubMed PubMed Citation Articles by Buseyne, F Articles by Rivière, Y

 Previous Article  |  Next Article 

J Virol. 1993 February; 67(2): 694-702

Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.

Unité de Virologie et Immunologie Cellulaire, URA CNRS 1157, Institut Pasteur, Paris, France.

ABSTRACT

Virus-specific cytotoxic T lymphocytes (CTL) may be an important host defense mechanism in the control of virus replication in persons infected with human immunodeficiency virus type 1 (HIV-1). Cytotoxic T-cell lines generated by nonspecific stimulation with anti-CD3 monoclonal antibodies and interleukin 2 were used to identify regions within the HIV-1 Gag protein that are the most frequently recognized. Using autologous Epstein-Barr virus-transformed target cells infected with recombinant vaccinia viruses encoding p18gag, p24gag, and p55gag proteins of HIV-1/Lai or selected truncations of p24gag, we show that within a group of 29 infected subjects, the p24gag protein is the target of Gag-specific CTL in most donors. Using autologous Epstein-Barr virus-transformed target cells coated with different synthetic peptides spanning the Gag amino acid sequence, we found clusters of partially overlapping peptides in three conserved regions of the p24 protein (amino acids [aa] 169 to 192, aa 219 to 304, and aa 335 to 372) that are frequently recognized by CTL and presented by a variety of human leukocyte antigen class I molecules. Since there are experiments both in vitro and in vivo showing the role of CTL in the control of virus replication in HIV and simian immunodeficiency virus infections, these results may be particularly important for vaccine development.

This article has been cited by other articles:

• Huang, X.-L., Fan, Z., Colleton, B. A., Buchli, R., Li, H., Hildebrand, W. H., Rinaldo, C. R. Jr. (2005). Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons. J. Virol. 79: 3052-3062 [Abstract] [Full Text]  
• Spira, S., Wainberg, M. A., Loemba, H., Turner, D., Brenner, B. G. (2003). Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 51: 229-240 [Abstract] [Full Text]  
• Novitsky, V., Cao, H., Rybak, N., Gilbert, P., McLane, M. F., Gaolekwe, S., Peter, T., Thior, I., Ndung'u, T., Marlink, R., Lee, T. H., Essex, M. (2002). Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C. J. Virol. 76: 10155-10168 [Abstract] [Full Text]  
• Day, C. L., Shea, A. K., Altfeld, M. A., Olson, D. P., Buchbinder, S. P., Hecht, F. M., Rosenberg, E. S., Walker, B. D., Kalams, S. A. (2001). Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA Alleles. J. Virol. 75: 6279-6291 [Abstract] [Full Text]  
• Buseyne, F., Chaix, M.-L., Rouzioux, C., Blanche, S., Rivière, Y. (2001). Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gag Epitope by HIV-1-Infected Children. J. Virol. 75: 4941-4946 [Abstract] [Full Text]  
• Voeten, J. T. M., Bestebroer, T. M., Nieuwkoop, N. J., Fouchier, R. A. M., Osterhaus, A. D. M. E., Rimmelzwaan, G. F. (2000). Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes. J. Virol. 74: 6800-6807 [Abstract] [Full Text]  
• Salerno-Gonçalves, R., Lu, W., Andrieu, J.-M. (2000). Quantitative Analysis of the Antiviral Activity of CD8+ T Cells from Human Immunodeficiency Virus-Positive Asymptomatic Patients with Different Rates of CD4+ T-Cell Decrease. J. Virol. 74: 6648-6651 [Abstract] [Full Text]  
• Iroegbu, J., Birk, M., Lazdina, U., Sonnerborg, A., Sallberg, M. (2000). Variability and Immunogenicity of Human Immunodeficiency Virus Type 1 p24 Gene Quasispecies. CVI 7: 377-383 [Abstract] [Full Text]  
• Polacino, P. S., Stallard, V., Klaniecki, J. E., Pennathur, S., Montefiori, D. C., Langlois, A. J., Richardson, B. A., Morton, W. R., Benveniste, R. E., Hu, S.-L. (1999). Role of Immune Responses against the Envelope and the Core Antigens of Simian Immunodeficiency Virus SIVmne in Protection against Homologous Cloned and Uncloned Virus Challenge in Macaques. J. Virol. 73: 8201-8215 [Abstract] [Full Text]  
• Balla-Jhagjhoorsingh, S. S., Koopman, G., Mooij, P., Haaksma, T. G. M., Teeuwsen, V. J. P., Bontrop, R. E., Heeney, J. L. (1999). Conserved CTL Epitopes Shared Between HIV-Infected Human Long-Term Survivors and Chimpanzees. J. Immunol. 162: 2308-2314 [Abstract] [Full Text]